PDA-Dependent Circulation #1: Pulmonary PDA Dependence (Ductal Pulmonary Blood Flow)

1. Core Concept

In pulmonary duct-dependent circulation, native antegrade blood flow from the ventricle to the pulmonary arteries is critically restricted or absent. Pulmonary blood flow therefore depends substantially—or completely—on flow through the patent ductus arteriosus (PDA) from the aorta to the pulmonary arteries (Ao → PA).

This physiology occurs in lesions with severe right ventricular outflow tract or pulmonary valvar obstruction, including severe tetralogy of Fallot (TOF), pulmonary atresia with intact ventricular septum (PA/IVS), critical pulmonary stenosis, and selected forms of transposition physiology with pulmonary outflow obstruction. In these patients, the ductus becomes a critical source of pulmonary blood flow and systemic oxygenation.

The essential physiologic sequence is:

Pulmonary outflow obstruction → inadequate native pulmonary blood flow → dependence on PDA flow from Ao to PA → ductal constriction → decreased pulmonary blood flow → progressive systemic desaturation.

The ductus is not merely an embryologic remnant in this setting. Its postnatal morphology reflects fetal flow conditions. Abnormal fetal hemodynamics in pulmonary outflow lesions can influence ductal size, curvature, and angulation, features that become clinically important when considering whether the ductus can serve as a stable transcatheter pathway after birth [1].

2. Why the Ductus Becomes Essential

During fetal life, pulmonary vascular resistance is high, and most right ventricular output passes through the ductus arteriosus into the descending aorta. After birth, lung expansion and falling pulmonary vascular resistance redirect right ventricular output toward the pulmonary circulation, while increased oxygen tension and decreasing prostaglandin concentrations promote ductal constriction.

In a normal neonate, ductal closure is appropriate because the right ventricle can deliver blood directly through the pulmonary valve. In a neonate with critical pulmonary outflow obstruction, however, the same transition removes an essential source of pulmonary blood flow.

When antegrade right ventricular ejection is severely restricted, systemic arterial pressure drives blood:

Aorta → PDA → pulmonary arteries → lungs

The degree of dependence varies. Some patients retain limited antegrade flow and are partially duct-dependent. Others, particularly those with complete pulmonary atresia and no alternative pulmonary blood supply, may be essentially completely duct-dependent.

3. Determinants of Pulmonary Blood Flow

Pulmonary blood flow through the PDA is determined by the interaction between ductal anatomy, pressure gradients, pulmonary vascular resistance, and residual native pulmonary blood flow. Important determinants include:

• Severity and level of pulmonary outflow obstruction
• PDA diameter, length, curvature, and insertion site
• Systemic and pulmonary arterial pressure
• Pulmonary vascular resistance and ductal vascular tone
• Presence of antegrade ventricular-to-pulmonary arterial flow
• Branch pulmonary artery anatomy
• Additional sources of pulmonary blood flow

The ductus should therefore not be considered simply “open” or “closed.” Progressive constriction may cause a clinically important reduction in pulmonary blood flow well before complete anatomical closure. When native pulmonary blood flow is negligible, even modest narrowing can markedly reduce pulmonary perfusion and systemic oxygen saturation.

Ductal morphology is also relevant to intervention. Fetal flow disturbances may produce tortuous, vertically oriented, or acutely angulated ducts. These features can affect vascular access, complete stent coverage, branch pulmonary artery distortion, and subsequent reintervention [1].

4. Representative Anatomic Lesions

Tetralogy of Fallot

Most infants with typical TOF have sufficient antegrade pulmonary blood flow without ductal support. In severe TOF with marked infundibular obstruction, pulmonary valvar stenosis, annular hypoplasia, or near-atresia, however, native pulmonary blood flow may be inadequate and the PDA becomes an important additional source.

At the extreme, TOF with pulmonary atresia may receive pulmonary blood flow from the ductus, major aortopulmonary collateral arteries, or both. Thus, ductal dependence is determined by the severity of pulmonary outflow obstruction and the available pulmonary arterial blood supply, not by the diagnosis of TOF alone.

Pulmonary Atresia With Intact Ventricular Septum

In PA/IVS, there is no direct communication across the pulmonary valve, and pulmonary blood flow is typically duct-dependent during the neonatal period.

Management must also define right ventricular size, tricuspid valve development, coronary anatomy, and right ventricle-to-coronary connections. In right-ventricle-dependent coronary circulation, indiscriminate right ventricular decompression can compromise coronary perfusion and precipitate myocardial ischemia. Ductal dependence must therefore be interpreted within the complete ventricular and coronary anatomy.

Critical Pulmonary Stenosis

Critical pulmonary stenosis usually retains some antegrade flow. Pulmonary perfusion may therefore be supplied by both:

Native RV → PA flow + ductal Ao → PA flow

After relief of pulmonary valve obstruction, a hypertrophied and poorly compliant right ventricle may initially remain unable to provide adequate pulmonary blood flow. Temporary continuation of ductal support may therefore be required even after technically successful valvar intervention.

TGA With VSD and Pulmonary Stenosis

Selected patients with d-transposition, VSD, and severe pulmonary stenosis or pulmonary atresia may also depend on the PDA for pulmonary blood flow. In this setting, systemic oxygenation depends on both adequate pulmonary perfusion and effective mixing between the parallel circulations. Ductal patency alone may therefore be insufficient if atrial-level mixing is restrictive.

5. Ductal Constriction and Clinical Deterioration

Ductal constriction narrows the pathway supplying systemic arterial blood to the pulmonary arteries:

Ductal constriction → decreased pulmonary blood flow → reduced pulmonary venous return → lower systemic arterial oxygen saturation → reduced systemic oxygen delivery → metabolic acidosis → cardiovascular deterioration

Clinical findings may include increasing cyanosis, falling oxygen saturation, tachypnea, poor feeding, lethargy, metabolic and lactic acidosis, and hemodynamic instability.

A key physiologic point is that supplemental oxygen cannot fully correct severe hypoxemia when the fundamental limitation is inadequate pulmonary blood flow. The lungs may be capable of normal gas exchange, but insufficient blood reaches the pulmonary capillary bed. Management must therefore restore or preserve flow rather than focus only on inspired oxygen concentration.

6. Immediate Stabilization: Maintaining Ductal Patency

When pulmonary duct-dependent circulation is suspected, prostaglandin E1 should be initiated promptly while the anatomy is being defined. Prostaglandin therapy maintains or re-establishes ductal patency and remains a fundamental bridge to definitive intervention [2].

Dose is individualized according to the degree of ductal constriction and clinical response. Lower doses may maintain an already patent ductus, whereas higher initial doses may be required when reopening a constricted ductus is necessary. The response should be assessed by oxygen saturation, systemic perfusion, lactate, acid-base status, and echocardiographic evidence of pulmonary blood flow.

Apnea is a clinically important adverse effect, particularly at higher doses, and airway support must be immediately available. The objective is not necessarily normal oxygen saturation; it is stable pulmonary blood flow and adequate systemic oxygen delivery.

7. Diagnostic Assessment

Echocardiography should establish both the intracardiac anatomy and the mechanism of pulmonary blood flow. Key questions include:

• Is there antegrade flow across the pulmonary valve?
• Where is the dominant obstruction?
• Are the branch pulmonary arteries confluent and adequately developed?
• What are the size, course, and insertion of the PDA?
• Is intracardiac mixing adequate?
• What are right ventricular size, function, and coronary anatomy?

Cross-sectional imaging or catheterization may be required when ductal morphology, pulmonary arteries, collateral supply, or coronary anatomy cannot be defined adequately by echocardiography.

When PDA stenting is considered, ductal length, tortuosity, origin, angle of entry, and pulmonary arterial insertion are particularly important because they determine whether complete and stable stent coverage can be achieved [1,2].

8. Transition From Temporary Ductal Support to Durable Pulmonary Blood Flow

Prostaglandin therapy is a bridge. A durable source of pulmonary blood flow must ultimately be established according to the underlying anatomy and intended final circulation.

Potential strategies include:

• Catheter-based pulmonary valvuloplasty
• Surgical pulmonary valvotomy
• Right ventricular outflow tract intervention
• PDA stenting
• Surgical systemic-to-pulmonary artery shunt
• Right ventricle-to-pulmonary artery connection
• Primary complete repair in selected anatomy

The available evidence for this topic is strongest for PDA stenting versus surgical systemic-to-pulmonary shunting. It does not provide an equivalent comparative evidence base for prostaglandin therapy, RV outflow interventions, or primary repair. These strategies should therefore remain lesion-specific rather than be interpreted as directly ranked alternatives.

9. PDA Stenting Versus Surgical Systemic-to-Pulmonary Shunt

PDA stenting has become an established alternative to surgical shunt placement in selected neonates with duct-dependent pulmonary blood flow. Contemporary procedural refinements have expanded its applicability, but patient selection and ductal morphology remain central [2].

In a multicenter Congenital Catheterization Research Collaborative analysis of 357 infants, including 106 PDA stents and 251 modified Blalock-Taussig shunts, the adjusted composite outcome of death or unplanned reintervention did not differ significantly between strategies. PDA stenting was associated with shorter ICU stay and fewer procedural complications, but reintervention was more common [3].

A UK multicenter national analysis comparing 83 ductal stents with 171 modified Blalock-Taussig shunts reported improved early survival and less need for extracorporeal support after ductal stenting [4]. These findings support the potential early advantage of avoiding surgical shunt placement in appropriately selected neonates.

However, the balance changes when the ductus is the sole source of pulmonary blood flow. In a multicenter cohort restricted to sole-source ductal-dependent pulmonary blood flow, interstage reintervention occurred substantially more often after PDA stenting than after surgical shunt placement: 48.6% versus 15.4% [5].

Reintervention is therefore a major consideration rather than an incidental outcome. In a multicenter cohort of 105 infants after ductal stenting, 39% required reintervention, with risk related to anatomic and procedural factors and the anticipated final physiology [6]. A larger database analysis of 936 neonates similarly found shorter hospitalization and lower costs with ductal stenting but a higher reintervention risk than with surgical systemic-to-pulmonary artery shunts [7].

A review of comparative studies reached a similar overall conclusion: ductal stenting can provide similar or improved early outcomes, fewer complications, and shorter hospitalization in selected patients, but at the cost of more frequent reintervention [8].

10. Surgical and Perioperative Decision-Making

The choice between PDA stenting and surgical shunt should therefore be individualized. Relevant considerations include ductal morphology, branch pulmonary artery anatomy, patient size and clinical stability, anticipated duration of palliation, need for concomitant surgery, institutional expertise, and the planned next stage of repair or palliation.

A favorable duct for stenting should permit reliable access and complete coverage from the systemic arterial origin to the pulmonary arterial insertion without compromising a branch pulmonary artery. A highly tortuous or complex duct can make this more difficult and may increase the risk of incomplete coverage or later reintervention [1,2].

A surgical shunt provides a surgically constructed and anatomically controlled source of pulmonary blood flow but introduces operative morbidity and systemic-to-pulmonary runoff. The decision is therefore not simply catheterization versus surgery; it is a determination of which strategy will provide the most reliable pulmonary blood flow for a specific anatomy and treatment pathway.

11. Key Clinical Perspective

Pulmonary PDA dependence is fundamentally a blood-flow problem rather than a primary pulmonary gas-exchange problem. Severe obstruction of the native ventricular-to-pulmonary pathway makes the ductus an alternative pulmonary inflow pathway. As long as the PDA remains sufficiently patent, systemic arterial blood can reach the lungs and support oxygenation. Once the ductus constricts, pulmonary perfusion may decline abruptly.

The central management sequence is:

Recognize duct-dependent pulmonary blood flow early → preserve ductal patency → define the native outflow tract, ductus, pulmonary arteries, ventricular and coronary anatomy → determine the intended final circulation → establish a durable pulmonary blood-flow source before ductal closure.

When palliation is required, PDA stenting and surgical systemic-to-pulmonary shunting are both valid strategies. Current comparative evidence suggests that ductal stenting may reduce early procedural morbidity and length of stay, but at the cost of more frequent reintervention, particularly when the ductus is the sole pulmonary blood-flow source [3-8]. The optimal strategy is therefore anatomy-specific rather than universal.

References

[1] Merlocco A. Fetal hemodymanic effects on ductus arteriosus development and influences on postnatal management in infants with ductal-dependent pulmonary blood flow. Congenit Heart Dis. 2019;14(1):100-104. (Tech Science)

[2] Aggarwal V, Petit CJ, Glatz AC, Goldstein BH, Qureshi AM. Stenting of the ductus arteriosus for ductal-dependent pulmonary blood flow—current techniques and procedural considerations. Congenit Heart Dis. 2019;14(1):110-115. (WashU Research Profiles)

[3] Glatz AC, Petit CJ, Goldstein BH, Kelleman MS, McCracken CE, McDonnell A, Buckey TM, Mascio CE, Shashidharan S, Ligon RA, Ao J, Whiteside W, Wallen WJ, Metcalf CM, Aggarwal V, Agrawal H, Qureshi AM. Comparison between patent ductus arteriosus stent and modified Blalock-Taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: Insights from the Congenital Catheterization Research Collaborative. Circulation. 2018;137(6):589-601. (PubMed)

[4] Bentham JR, Zava NK, Harrison WJ, Shauq A, Kalantre A, Derrick G, Chen RH, Dhillon R, Taliotis D, Kang SL, Crossland D, Adesokan A, Hermuzi A, Kudumula V, Yong S, Noonan P, Hayes N, Stumper O, Thomson JDR. Duct stenting versus modified Blalock-Taussig shunt in neonates with duct-dependent pulmonary blood flow: Associations with clinical outcomes in a multicenter national study. Circulation. 2018;137(6):581-588. (PubMed)

[5] Bauser-Heaton H, Qureshi AM, Goldstein BH, Glatz AC, Ligon RA, Gartenberg A, Aggarwal V, Shashidharan S, McCracken CE, Kelleman MS, Petit CJ. Comparison of patent ductus arteriosus stent and Blalock-Taussig shunt as palliation for neonates with sole source ductal-dependent pulmonary blood flow: Results from the Congenital Catheterization Research Collaborative. Pediatr Cardiol. 2022;43(1):121-131. (PubMed)

[6] Shahanavaz S, Qureshi AM, Petit CJ, Goldstein BH, Glatz AC, Bauser-Heaton HD, McCracken CE, Kelleman MS, Law MA, Nicholson GT, Zampi JD, Pettus JA, Meadows J. Factors influencing reintervention following ductal artery stent implantation for ductal-dependent pulmonary blood flow: Results from the Congenital Cardiac Research Collaborative. Circ Cardiovasc Interv. 2021;14(12):e010086. (PubMed)

[7] Valencia E, Staffa SJ, Kuntz MT, Zaleski KL, Kaza AK, Maschietto N, Nasr VG. Transcatheter ductal stents versus surgical systemic-pulmonary artery shunts in neonates with congenital heart disease with ductal-dependent pulmonary blood flow: Trends and associated outcomes from the Pediatric Health Information System database. J Am Heart Assoc. 2023;12(17):e030528. (PubMed)

[8] Boucek DM, Qureshi AM, Goldstein BH, Petit CJ, Glatz AC. Blalock-Taussig shunt versus patent ductus arteriosus stent as first palliation for ductal-dependent pulmonary circulation lesions: A review of the literature. Congenit Heart Dis. 2019;14(1):105-109. (WashU Research Profiles)